Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population-Reference-Cited by-同舟云学术

Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population

Published:2020-09-11 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Qi Yalong,Liao Daixiang,Mei Dinglian,Zhang Yong,Liu Yang

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference67 articles.

1. Chinese guidelines on the diagnosis and treatment of melanoma (2015 edition);Guo;Chin Clin Oncol.,2016

2. Clinical characteristics of malignant melanoma in Southwest China: a single-center series of 82 consecutive cases and a meta-analysis of 958 reported cases;Yu;PLoS ONE.,2016

3. Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases;Leichsenring;Pathology.,2018

4. Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade;Betof;J Clin Oncol.,2020

5. Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the CA209-003 study;Gettinger;J Clin Oncol.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study;Cell Reports Medicine;2023-12

2. Baseline neutrophil-to- ratio combined with the change during treatment provides risk stratification for metastatic malignant melanoma patients treated with PD-1 inhibitors in a Chinese population;Frontiers in Oncology;2023-04-21

3. Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma;Frontiers in Oncology;2022-10-31

4. Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?;Medicina;2022-10-06

5. Clinical predictors of survival in real world practice in stage IV melanoma;Cancer Reports;2022-09-25